Teva Is on the Prowl and Its Stock Investors Are Taking Notice

By Gabrielle Coppola

March 30, 2015 at 3:33 AM EDT

Updated on

March 29, 2015 at 9:28 AM EDT

This article is for subscribers only.

Executives at Teva Pharmaceutical Industries Ltd., the world’s biggest generic drugmaker, keep dropping hints that they’re ready to make a large acquisition.

Investors are taking them seriously.

Have a confidential tip for our reporters? Get in Touch

Before it’s here, it’s on the Bloomberg Terminal

LEARN MORE